Molbio Diagnostics Ltd vs Shree Pacetronix Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1237 as of 23 Oct 15:30 . The P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Shree Pacetronix Ltd changed from 77.1 on March 2021 to 10.9 on March 2026 . This represents a CAGR of -27.82% over 6 years The Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Shree Pacetronix Ltd changed from ₹ 4.16 crore on March 2021 to ₹ 34.33 crore on March 2026 . This represents a CAGR of 42.16% over 6 years The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The revenue of Shree Pacetronix Ltd for the Jun '26 is ₹ 4.92 crore as compare to the Mar '26 revenue of ₹ 5.41 crore. This represent the decline of -9.06% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The ebitda of Shree Pacetronix Ltd for the Jun '26 is ₹ 1.21 crore as compare to the Mar '26 ebitda of ₹ 1.68 crore. This represent the decline of -27.98% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The net profit of Shree Pacetronix Ltd changed from ₹ 0.37 crore to ₹ 0.76 crore over 9 quarters. This represents a CAGR of 37.70% The Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Shree Pacetronix Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

About Shree Pacetronix Ltd

Shree Pacetronix Limited, a leading manufacturer / exporter of Pacemakers, was incorporated in January 1988 as a Private Limited Company and converted into a Public Limited Company in 1993.
It has a plant at Pithampur, Madhya Pradesh with installed capacity to produce 4800 pacemakers per annum. Pacemakers are used to treat patients suffering mainly from heart conditions, such as heart failure and arrhythmias.
These devices are implanted under patient's chest by cardiologist to deal with various indications and used for the treatment of heart medical conditions.
Innovations such as longer-lasting batteries, advanced remote monitoring capabilities, and next-generation leadless and MRI-safe pacemakers are key pillars of the R&D agenda.
These developments not only improve clinical outcomes but also align with evolving patient needs and healthcare provider expectations, allowing to maintain a competitive edge in the rapidly advancing pacemaker industry.

FAQs for the comparison of null and Shree Pacetronix Ltd

Which company has a larger market capitalization, Molbio Diagnostics Ltd or Shree Pacetronix Ltd?

Market cap of Molbio Diagnostics Ltd is 14,262 Cr while Market cap of Shree Pacetronix Ltd is 59 Cr

What are the key factors driving the stock performance of Molbio Diagnostics Ltd and Shree Pacetronix Ltd?

The stock performance of Molbio Diagnostics Ltd and Shree Pacetronix Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Molbio Diagnostics Ltd and Shree Pacetronix Ltd?

As of October 25, 2026, the Molbio Diagnostics Ltd stock price is INR ₹1237.65. On the other hand, Shree Pacetronix Ltd stock price is INR ₹158.1.

How do dividend payouts of Molbio Diagnostics Ltd and Shree Pacetronix Ltd compare?

To compare the dividend payouts of Molbio Diagnostics Ltd and Shree Pacetronix Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.